Cytidine deamination of retroviral DNA by diverse APOBEC proteins

Current Biology

Volumn 14, Issue 15, 2004, Pages 1392-1396

  Bishop, Kate N ^a   Holmes, Rebecca K ^a   Sheehy, Ann M ^a   Davidson, Nicholas O ^b   Cho, Soo Jin ^b   Malim, Michael H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; APOLIPOPROTEIN B; APOLIPOPROTEIN B MRNA EDITING ENZYME; COMPLEMENTARY DNA; CYTIDINE DEAMINASE; PRIMER DNA;

ARTICLE; COMPARATIVE STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOBLOTTING; METABOLISM; MURINE LEUKEMIA VIRUS; PATHOGENICITY; PLASMID; REGULATOR GENE; RNA PROCESSING;

ANTIVIRAL AGENTS; APOLIPOPROTEINS B; CYTIDINE DEAMINASE; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, VIF; HIV; HUMANS; IMMUNOBLOTTING; LEUKEMIA VIRUS, MURINE; PLASMIDS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RODENTIA;

EID: 4143092717     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.06.057     Document Type: Article

References (30)

1. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell. 113:2003;803-809
2. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 424:2003;99-103
3. Mariani R., Chen D., Schröfelbauer B., Navarro F., König R., Bollman B., Münk C., Nymark-McMahon H., Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 114:2003;21-31
4. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418:2002;646-650
5. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 424:2003;94-98
6. Vartanian J.P., Meyerhans A., Asjo B., Wain-Hobson S. Selection, recombination, and G->A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1991;1779-1788
7. Vartanian J.P., Sommer P., Wain-Hobson S. Death and the retrovirus. Trends Mol. Med. 9:2003;409-413
8. Janini M., Rogers M., Birx D.R., McCutchan F.E. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J. Virol. 75:2001;7973-7986
9. Yu Q., Konig R., Pillai S., Chiles K., Kearney M., Palmer S., Richman D., Coffin J.M., Landau N.R. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11:2004;435-442
10. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 300:2003;1112
11. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 302:2003;1056-1060
12. Stopak K., de Noronha C., Yonemoto W., Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell. 12:2003;591-601
13. Sheehy A.M., Gaddis N.C., Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9:2003;1404-1407
14. Marin M., Rose K.M., Kozak S.L., Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9:2003;1398-1403
15. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 79:2002;285-296
16. Wiegand H.L., Doehle B.P., Bogerd H.P., Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23:2004;2451-2458
17. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 Replication. J. Virol. 78:2004;6073-6076
18. Bogerd H.P., Doehle B.P., Wiegand H.L., Cullen B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA. 101:2004;3770-3774
19. Mangeat B., Turelli P., Liao S., Trono D. A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279:2004;14481-14483
20. Schröfelbauer B., Chen D., Landau N.R. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. USA. 101:2004;3927-3932
21. Xu H., Svarovskaia E.S., Barr R., Zhang Y., Khan M.A., Strebel K., Pathak V.K. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. USA. 101:2004;5652-5657
22. Teng B., Burant C.F., Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1993;1816-1819
23. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:2002;99-103
24. Neuberger M.S., Harris R.S., Di Noia J., Petersen-Mahrt S.K. Immunity through DNA deamination. Trends Biochem. Sci. 28:2003;305-312
25. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10:2002;1247-1253
26. Anant S., Davidson N.O. Hydrolytic nucleoside and nucleotide deamination, and genetic instability. a possible link between RNA-editing enzymes and cancer? Trends Mol. Med. 9:2003;147-152
27. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes. correlation with mutation spectra in vivo J. Mol. Biol. 337:2004;585-596
28. + T lymphocytes. J. Virol. 66:1992;6489-6495
29. von Schwedler U., Song J., Aiken C., Trono D. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955
30. Liddament, M.T., Brown, W.L., Schumacher, A.J., and Harris, R.S. (2004). APOBEC properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, in press.